Loading insider details...
Beta
Latest Form 4 (Sep 22, 2026): Grant/Award of 5,750 SCYX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 22, 2026 | SCYNEXIS INC (SCYX) | Grant/Award | 5,750 | n/a |
| Feb 4, 2026 | Akebia Therapeutics, Inc. (AKBA) | Sale | 21,582 | $30.0K |
| Feb 3, 2026 | Akebia Therapeutics, Inc. (AKBA) | Grant/Award | 204,000 | n/a |
| Mar 4, 2025 | Akebia Therapeutics, Inc. (AKBA) | Sale | 7,144 | $13.1K |
| Feb 4, 2025 | Akebia Therapeutics, Inc. (AKBA) | Grant/Award | 194,900 | n/a |
| May 9, 2024 | Akebia Therapeutics, Inc. (AKBA) | Sale | 27,000 | $31.0K |
| Mar 1, 2024 | Akebia Therapeutics, Inc. (AKBA) | Sale | 7,169 | $11.3K |
| Feb 29, 2024 | Akebia Therapeutics, Inc. (AKBA) | Sale | 8,367 | $12.7K |
| Feb 2, 2024 | Akebia Therapeutics, Inc. (AKBA) | Grant/Award | 202,200 | n/a |
| May 18, 2023 | Akebia Therapeutics, Inc. (AKBA) | Sale | 63,567 | $67.9K |